[Referral criteria for benign prostatic hyperplasia in primary care].

Atencion primaria
J M MoleroJ M Cozar Olmo

Abstract

Benign prostatic hyperplasia (BPH) is a high prevalence condition in men over 50 years that requires continued assistance between primary care and urology. Therefore, consensus around common referral criteria was needed to guide and support both levels. Medical history, symptom assessment with International Prostate Symptom Score (IPSS) questionnaire, digital rectal examination and prostate-specific antigen (PSA) measurement are diagnostic tests available for general practitioners that allow setting a correct BPH diagnose. Patients with an IPSS<8 should be monitored by evaluating them annually. Treatment with alpha-blockers and an evaluation at the first and third month is recommended in patients with an IPSS 8-20 and if the prostate is small, if the prostate size is large treatment with alpha-blockers or 5alpha-reductase inhibitors and evaluation at the third and six month is recommended, and in patients with a large prostate and a PSA >1.5 ng/ml combined treatment and evaluation at the first and sixth month is recommended. Some clear criteria for referral to urology are established in this document, which help in the management of these patients. Those patients with BPH who do not show any improvement at the third month of tr...Continue Reading

References

Jan 1, 1989·The Prostate. Supplement·J T Isaacs, D S Coffey
Aug 18, 1993·JAMA : the Journal of the American Medical Association·J E OesterlingM M Lieber
Nov 14, 2000·Urology·F M Debruyne
Sep 28, 2002·Urology·Claus G RoehrbornUNKNOWN ARIA3001 ARIA3002 and ARIA3003 Study Investigators
Sep 12, 2003·The New England Journal of Medicine·Gil Porat
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group
Jan 31, 2006·Urology·Robert B NadlerUNKNOWN Chronic Prostatitis Collaborative Research Network
Feb 2, 2006·CA: a Cancer Journal for Clinicians·Robert A SmithHarmon J Eyre

❮ Previous
Next ❯

Citations

Oct 1, 2011·Actas urologicas españolas·J M CozarI Pérez-Escolano
Apr 24, 2013·Actas urologicas españolas·C HernándezJ M Cózar
Dec 19, 2012·Actas urologicas españolas·D Castro-DíazM Pérez
Oct 20, 2012·Actas urologicas españolas·J M CozarUNKNOWN en representación del Comité Científico del estudio Manejo asistencial de pacientes con hiperplasia benigna de próstata en E
Apr 6, 2012·Actas urologicas españolas·J M Cózar-OlmoF Caballero-Martínez
Oct 11, 2015·Semergen·A Alcántara MonteroD Pérez Feito
Jan 3, 2015·Actas urologicas españolas·R Sopeña-SutilJ B Passas-Martínez
Dec 18, 2013·Atencion primaria·Jorge Navarro-PérezUNKNOWN en nombre del Grupo de trabajo del Programa de Formación e Investigación en Hiperplasia Benigna de Próstata de la Comunidad
Jul 2, 2020·International Journal of Clinical Practice·José María MoleroRafael Cuervo Pinto
Apr 9, 2020·Ciência & saúde coletiva·Natan KatzRoberto Nunes Umpierre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.